Advancing the global public health agenda for NAFLD: a consensus statement

dc.contributor.authorLazarus, Jeffrey, V
dc.contributor.authorMark, Henry E.
dc.contributor.authorAnstee, Quentin M.
dc.contributor.authorArab, Juan Pablo
dc.contributor.authorBatterham, Rachel L.
dc.contributor.authorCastera, Laurent
dc.contributor.authorCortez-Pinto, Helena
dc.contributor.authorCrespo, Javier
dc.contributor.authorCusi, Kenneth
dc.contributor.authorDirac, M. Ashworth
dc.contributor.authorFrancque, Sven
dc.contributor.authorGeorge, Jacob
dc.contributor.authorHagstrom, Hannes
dc.contributor.authorHuang, Terry T-K
dc.contributor.authorIsmail, Mona H.
dc.contributor.authorKautz, Achim
dc.contributor.authorSarin, Shiv Kumar
dc.contributor.authorLoomba, Rohit
dc.contributor.authorMiller, Veronica
dc.contributor.authorNewsome, Philip N.
dc.contributor.authorNinburg, Michael
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorRatziu, Vlad
dc.contributor.authorRinella, Mary
dc.contributor.authorRomero, Diana
dc.contributor.authorRomero-Gomez, Manuel
dc.contributor.authorSchattenberg, Jorn M.
dc.contributor.authorTsochatzis, Emmanuel A.
dc.contributor.authorValenti, Luca
dc.contributor.authorWong, Vincent Wai-Sun
dc.contributor.authorYilmaz, Yusuf
dc.contributor.authorYounossi, Zobair M.
dc.contributor.authorZelber-Sagi, Shira
dc.date.accessioned2025-01-20T22:01:41Z
dc.date.available2025-01-20T22:01:41Z
dc.date.issued2022
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.
dc.fuente.origenWOS
dc.identifier.doi10.1038/s41575-021-00523-4
dc.identifier.eissn1759-5053
dc.identifier.issn1759-5045
dc.identifier.urihttps://doi.org/10.1038/s41575-021-00523-4
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93870
dc.identifier.wosidWOS:000712475600002
dc.issue.numero1
dc.language.isoen
dc.pagina.final78
dc.pagina.inicio60
dc.revistaNature reviews gastroenterology & hepatology
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAdvancing the global public health agenda for NAFLD: a consensus statement
dc.typeartículo
dc.volumen19
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files